What evidence do US payers want to see? Nicole Lodowski, our US Evidence Lead, shares key insights on the variability of payer preferences in the US. With no fixed government requirements or HTA-style body, evidence needs can differ not only by payer but also from year to year, or even day to day. Nicole has even received contrasting views from payers within the same organisation about the same product. With a heterogenous mix of payers in the US, and differential needs by therapeutic area/product, a bespoke strategic approach to evidence is required for every launch in the US. So, how can you effectively prepare evidence for the US market? 💡 Connect with Nicole and our Global Team to discuss tailored strategies for your market launch 📧 Get in touch at [email protected] Watch the full webinar (first broadcast in October 2024) here: https://lnkd.in/ePvNjAJJ #GlobalWhispers #USpayerevidence #marketaccess #pharma #medtech